| Series
Calendar: |
| 9/18/2009
|
Dr. Meenhard Herlyn |
Understanding the Biology of Melanoma Development & Progression to Develop New Strategies for Therapy |
| 2/27/2009
|
Dr. Jenny Ting |
Genomic Discovery of New Innate and Adaptive Immune Genes |
| 2/20/2009
|
Dr. Ulrich Siebenlist |
New Frontiers for NF-KappaB Transcription Factors |
| 2/6/2009
|
Dr. Bin Gao |
STAT3, Inflammation, and Liver Disease |
| 2/6/2009
|
Dr. Lee Helman |
Targeting the IGF Pathway in Pediatric Sarcomas-Lessons Learned and Questions Raised |
| 1/16/2009
|
Dr. Joel Linden |
Adenosine Inhibits Ischemia-Reperfusion Injury and Sickle Cell Disease by Inactivating NKT and NK Cells |
| 12/8/2008
|
Dr. Derya Unutmaz |
Mechanisms of Human Regulatory T Cell Function |
| 12/5/2008
|
Dr. Philip Bergman |
Of Mice and Men (and DOGS!): Xenogeneic DNA Vaccines for Malignant Melanoma |
| 11/21/2008
|
Dr. Jacques Banchereau |
Harnessing Dendritic Cells for Better Human Health |
| 11/14/2008
|
Dr. Bob Strieter |
Circulating Mesenchymal Progenitor Cells(Fibrocytes) Contribute to the Pathogenesis of Pulmonary Fibrosis and Metabolic Syndrome |
| 10/24/2008
|
Dr. Ann Marie Schmidt |
RAGE and the Inflammatory Response - Implications for Diverse Biological Settings |
| 10/17/2008
|
Dr. Glenn Merlino |
Modeling UV-Induced Melanoma in the Mouse |
| 10/10/2008
|
Dr. Saraswati Sukumar |
Gaining Insight into the Multiple Facets of HOXB7 Action in Breast Cancer Through Human and Mouse Models |
| 9/26/2008
|
Dr. Barbara Rehermann |
Host Responses Involved in the Control of Hepatitis C Virus Infection |
| 9/19/2008
|
Dr. David Weiner |
Directing and Enhancing DNA Vaccine Technology in Models Relevant to Cancer and Infectious Diseases |
| 9/5/2008
|
Dr. Paul Sondel, MD, PhD |
Development of hu14.18-IL2 for GD2+ Tumors |
| 6/27/2008
|
Dr. Allan Hildesheim |
Natural History and Vaccination Studies of Human Papillomavirus Infection & Immunity |
| 6/17/2008
|
Siamon Gordon, PhD |
Role of Macrophage Receptors in Innate Immunity |
| 6/13/2008
|
Dr. Glenn Merlino |
Seminar is Cancelled----Modeling Melanoma Progression in the Mouse |
| 6/6/2008
|
Dr. Steven Coats |
A Bispecific Approach to Stimulate Targeted T-Cell Mediated Tumor Cell Killing |
| 5/30/2008
|
Dr. Peter Parham |
Evolution of A Variable Family of Natural Killer Cell Receptors |
| 5/23/2008
|
Dr. Terry Van Dyke |
Deciphering the Complexities of Cancer Pathways and Mechanisms In Vivo |
| 5/16/2008
|
Dr. Mitchell Kronenberg |
Innate-Like Responses to Microbes by Natural Killer T Cells |
| 5/9/2008
|
Dr. Anjana Rao |
Signal Transduction and Gene Expression in Lymphocytes |
| 5/2/2008
|
Dr. Tyler Curiel |
Regulatory T Cells and Tumor Immunotherapy |
| 4/25/2008
|
Dr. Jedd Wolchok |
CANCELLED-The Reality of Immunotherapy for Melanoma |
| 4/18/2008
|
Dr. Judith Kapp |
Induction and Function of FoxP3gfp+ TCR Transgenic T Cells |
| 3/21/2008
|
Dr. Stephan R. Targan |
Central Role for TL1A (TNSF15)in Chronic Mucosal Inflammation: A New Target for Treatment of Crohn's Disease |
| 3/14/2008
|
Dr. Gene Shearer |
HIV-1 Immunopathogenesis: Hijacking Immune Regulatory Mechanisms |
| 3/7/2008
|
Dr. Stephen Miller |
A Dual Role for Anergy and Regulatory T Cells in Cell-Coupled Tolerance for Therapy of Established T Cell-Mediated Autoimmune Disease |
| 2/29/2008
|
Dr. Jill Smith |
Opioid Receptors and Inflammatory Bowel Disease |
| 2/22/2008
|
Dr. Philip Bergman |
CANCELLED-Of Mice & Men (and DOGS!): Xenogeneic DNA Vaccines for Malignant Melanoma |
| 2/15/2008
|
Dr. Stuart Yuspa |
Inflammatory Mediators of Cutaneous Carcinogenesis: Evidence for an Autocrine Mechanism of Action |
| 2/8/2008
|
Robert M. Strieter, MD |
CANCELLED--Circulating Mesenchymal Progenitor Cells (Fibrocytes) Contribute to the Pathogenesis of Pulmonary Fibrosis and Metabolic Syndrome |
| 2/1/2008
|
Dr. Madhav V. Dhodapkar, MD |
Probing Targets of Immunity in Human Premalignancy and Inflammation |
| 1/25/2008
|
Dr. Bali Pulendran |
Modulating Vaccine Responses with Innate Immunity |
| 1/18/2008
|
Dr. Warren Trober |
The Regulation of Gut Homeostasis by NOD2 Signaling |
| 1/11/2008
|
Andrew Mellor, PhD |
Tryptophan Catabolism and Immune Privilege: A Loophole for Bio-Terrorists? |
| 12/7/2007
|
Gary J. Nabel, M.D., Ph.D., Director |
HIV Trafficking and Assembly: Relevance to Immunogenicity and Vaccine Design |
| 12/7/2007
|
Dr. Gary Nabel |
HIV Trafficking and Assembly: Relevance to Immunogenicity and Vaccine Design |
| 11/30/2007
|
Dr. William Paul |
The2 Cells: Differentiation and Repertoire-dependent Immunopathology |
| 11/16/2007
|
Dr. Licia Selleri |
A First Step Towards a Genetic and Transcriptional Control of Spleen Development |
| 11/9/2007
|
Hal E. Broxmeyer, PhD |
Regulation of Hematopoietic and Embryonic Stem Cells |
| 11/9/2007
|
Dr. Hal Broxmeyer |
Regulation of Hematopoietic and Embryonic Stem Cells |
| 11/2/2007
|
Dr. Robert Strieter |
CANCELLED-Circulating Mesenchymal Progenitor Cells (Fibrocytes) Contribute to the Pathogenesis of Pulmonary Fibrosis and Metabolic Syndrome |
| 10/19/2007
|
Fabio Cominelli, PhD |
New Concepts in the Pathogenesis and Treatment of Crohn's Disease |
| 10/12/2007
|
Dr. Paula Pitha-Rowe |
Cell Defense Against Viral Offense; Role of IRF Family |
| 10/5/2007
|
Alan M. Krensky, MD |
Granulysin: A Host Defense Molecule |
| 9/28/2007
|
Dr. Christopher A. Hunter |
Suppressive Effects of IL-27 |
| 9/21/2007
|
Dr. Hua Yu |
Stat3 as a Target for Cancer Therapy |
| 8/29/2007
|
Roberto S. Accolla, MD, PhD |
The Significance of Antigen Availability in Tumor Immunology: A Tribute to N.A. Mitchison |
| 6/22/2007
|
Anthony J. Coyle, Ph.D. |
HMGB1-A Mediator of Inflammation & Autoimmunity |
| 6/8/2007
|
Dr. Thomas Rogers |
Biochemical Basis for the Cross-Talk Between Muopioid Receptors and CCR5 |
| 6/1/2007
|
Dr. Esteban Celis |
Design of Improved Vaccines for Cancer |
| 5/25/2007
|
Dragana Jankovic, PhD |
Conventional Th1 Effector Lymphoccytes can Regulate Immunopathology Through the Production of IL-10 |
| 5/11/2007
|
Dr. David McConkey |
TRAIL-Based Combination Therapy in Solid Tumors |
| 5/4/2007
|
Dr. Andrew Larner |
The Role of Jak/Stat Pathway in Mitochondrial Function |
| 4/27/2007
|
Victor H. Englehard, Ph.D. |
Strategies and Challenges in Eliciting Immunity to Melanoma |
| 4/20/2007
|
Dr. Gerald Krystal |
The Role of SHIP in Macrophage Activation and Polarization |
| 4/6/2007
|
Dr. Weiping Zou |
Immunosuppressive Networks in the Tumor Environment and Their Therapeutic Relevance |
| 3/21/2007
|
Olivera J. Finn, PhD |
Human Self/Tumor Antigens and a New Vision of (Cancer) Immunosurveillance |
| 3/16/2007
|
Dr. Samuel Baron |
Is Total Eradication of Some Human Tumors Possible Using Interferon-Activated Monocytes? |
| 3/9/2007
|
Dr. Andrew P. Makrigiannis |
Self-Recognizing Mechanisms in Natural Killer and Plasmacytoid Dendritic Cells |
| 3/2/2007
|
Michael T. Lotze, MD |
Dying Dangerously: Damage Associated Molecular Pattern Molecules and Cancer |
| 2/23/2007
|
Jian Jian Li, PhD |
Molecular Targets to Resensitize Radiation Resistant Tumor Cells: NF-kappaB Regulated Network |
| 2/9/2007
|
Stephen Shaw, MD |
Lymphocyte Cytoskeleton: Biochemical and Functional Analysis of ERMs in Migration and Recognition |
| 1/26/2007
|
Helene F. Rosenberg, MD |
RNase A Ribonucleases, Evolution and Host Defense: Solving the Puzzle |
| 1/5/2007
|
David Spencer, Ph.D. |
Genetically Enhanced Dendritic Cells (eDCs): Novel 3rd Generation DC Vaccine Platform Technology For Cancer |
